Americans understandably are concerned about the recent surge of cases of COVID-19 driven by the omicron variant of the coronavirus. Here are answers to some of the more common questions about omicron.
Jan 5, 2022
0
13
COVID cases have increased in Philadelphia about 40% over the past month—and that's without counting the scores of people testing positive at home as the latest BA.5 omicron variant surges across the country.
Jul 28, 2022
0
10
Amid reports of waning COVID-19 immunity, the Food and Drug Administration (FDA) is expected to officially approve a third dose of messengerRNA vaccines for the general public. Moderna and Pfizer are mRNA vaccines.
Aug 26, 2021
0
191
A new study on Chile's national COVID-19 vaccination program, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Global ...
Apr 24, 2022
0
32
White parents reported higher use of age-appropriate car seats for one- to seven-year-old children than non-white parents, according to a new University of Michigan study published today in Pediatrics.
Jan 13, 2014
0
0
COVID-19 vaccine choices are getting more complicated. So don't feel bad if you are confused about the different COVID-19 vaccines and who's eligible for what. In addition to the three original vaccines approved by the Food ...
Oct 8, 2021
0
41
A team of researchers working at Israel's Sheba Medical Center has found evidence that suggests a fourth COVID vaccination or second booster shot may not be necessary for most people because it does not add significant protection. ...
Vaccine drugmaker Pfizer says its studies show three doses of its COVID-19 vaccine neutralized the omicron variant while two doses reduced severity.
Dec 10, 2021
0
22
Despite not knowing how long another jab might provide protection, the Biden administration plans to offer a second COVID booster shot to Americans 50 and older.
Mar 28, 2022
0
71
According to an accepted manuscript published in ARRS' American Journal of Roentgenology (AJR), axillary lymphadenopathy after a COVID-19 vaccine booster dose has a mean time to resolution of 102 days, shorter than the time ...
Mar 9, 2023
0
35
